Wordt geladen...
Advances in the development of new biologics in inflammatory bowel disease
Biologics have revolutionized the therapeutic approach in inflammatory bowel disease (IBD). Anti-tumor necrosis factor (anti-TNF) agents infliximab and adalimumab currently constitute the major biological therapy in IBD. Additional anti-TNFs such as golimumab and other new biologics are currently be...
Bewaard in:
| Gepubliceerd in: | Ann Gastroenterol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hellenic Society of Gastroenterology
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4923809/ https://ncbi.nlm.nih.gov/pubmed/27366024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2016.0027 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|